Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-27 @ 5:22 AM
Study NCT ID:
NCT05787860
Status:
COMPLETED
Last Update Posted:
2025-05-06
First Post:
2023-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ruxolitinib in Seborrheic Dermatitis
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-15
First Submit QC Date:
None
Study First Post Date:
2023-03-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-11
Results First Submit QC Date:
None
Results First Post Date:
2025-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-05
Last Update Post Date:
2025-05-06
Last Update Post Date Type:
ACTUAL